Honokiol in glioblastoma recurrence: a case report

Glioblastoma is the most common and aggressive primary tumor in the central nervous system. There is no standard of care for patients with recurrent GBM. Honokiol is a pleiotropic lignan and has the potential to be a potent and safe anticancer agent in human GBM when it is encapsulated by liposomes. We report an efficient and safe response to three phases of treatment with liposomal honokiol in a patient with recurrent glioblastoma.

Automated summary

This article reports an efficient and safe response to three phases of treatment with liposomal honokiol in a patient with recurrent glioblastoma, suggesting its potential as a potent and safe anticancer agent.